ABT-450: a novel agent for the treatment of CHC genotype 1: focus on treatment-experienced patients. [electronic resource]
Producer: 20151019Description: 295-304 p. digitalISSN:- 1744-8336
- 2-Naphthylamine
- Anilides -- therapeutic use
- Antiviral Agents -- therapeutic use
- Carbamates -- therapeutic use
- Carcinoma, Hepatocellular -- virology
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Cyclopropanes
- Drug Interactions
- Drug Resistance, Viral
- Drug Therapy, Combination
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- complications
- Humans
- Lactams, Macrocyclic
- Liver Cirrhosis -- virology
- Liver Neoplasms -- virology
- Macrocyclic Compounds -- therapeutic use
- Proline -- analogs & derivatives
- Protease Inhibitors -- therapeutic use
- RNA, Viral
- Randomized Controlled Trials as Topic
- Ribavirin -- therapeutic use
- Ritonavir -- therapeutic use
- Sulfonamides -- therapeutic use
- Uracil -- analogs & derivatives
- Valine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.